264 LigT-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 2 | 5.3 | 0.38× | q = 0.10 | |
| Organic oxygen compounds | 5 | 2.2 | 2.31× | not tested | |
| Nucleosides, nucleotides, and analogues | 6 | 3.0 | 2.00× | not tested | |
| Homogeneous non-metal compounds | 4 | 2.3 | 1.71× | not tested | |
| Organoheterocyclic compounds | 1 | 1.7 | 0.60× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 7 |
| DB03685 | U5P | Uridine monophosphate | 4 |
| DB00171 | ATP | ATP | 3 |
| DB02098 | A2P | Adenosine-2'-5'-Diphosphate | 3 |
| DB02580 | PG6 | Pentaglyme | 3 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB03512 | UVC | Uridine-2',3'-vanadate | 1 |
| DB04205 | THP | Thymidine-3',5'-Diphosphate | 1 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 29 |
| 2AM | ADENOSINE-2'-MONOPHOSPHATE | 10 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 7 |
| OVE | 2'-O-(sulfidophosphinato)adenosine | 4 |
| U5P | URIDINE-5'-MONOPHOSPHATE | 4 |
| A2P | ADENOSINE-2'-5'-DIPHOSPHATE | 3 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 3 |
| CAmetal | CALCIUM ION | 3 |
| PG6 | 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE | 3 |
| 3AM | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| 15P | POLYETHYLENE GLYCOL (N=34) | 1 |
| ACK | 2',3'- cyclic AMP | 1 |
| AMP | ADENOSINE MONOPHOSPHATE | 1 |
| C5P | CYTIDINE-5'-MONOPHOSPHATE | 1 |
| GDP | GUANOSINE-5'-DIPHOSPHATE | 1 |
| HGmetal | MERCURY (II) ION | 1 |
| QQX | [(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2-oxidanyl-2-sulfanylidene-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-6-yl]methanol | 1 |
| QQY | [(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2-oxidanylidene-2-sulfanyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-6-yl]methanol | 1 |
| THP | THYMIDINE-3',5'-DIPHOSPHATE | 1 |